| Non-treated controls1,2 | Indoxacarb1,2 |
---|
Study day3 | % Adult emergence4 | Predicted emergence5 | % Adult emergence4 | Predicted emergence5 | Efficacy6 |
---|
1 | 50.1a | 327.9 | 4.6 b | 10.2 | 96.9 |
2 | 46.1a | 289.6 | 0.0b | 0.0 | 100.0 |
3 | 67.0a | 395.2 | 0.0b | 0.0 | 100.0 |
9 | 77.1 | 501.8 | NE | 0.0 | 100.0 |
10 | 79.8 | 763.7 | NE | 0.0 | 100.0 |
16 | 75.3 | 345.5 | NE | 0.0 | 100.0 |
17 | 76.4 | 524.2 | NE | 0.0 | 100.0 |
23 | 84.3 | 623.2 | NE | 0.0 | 100.0 |
24 | 83.6 | 908.2 | NE | 0.0 | 100.0 |
30 | 77.0 | 436.2 | NE | 0.0 | 100.0 |
31 | 85.2a | 604.0 | 0.0b | 0.0 | 100.0 |
37 | 75.4a | 370.2 | 20.0b | 0.1 | 99.9 |
38 | 63.7a | 388.6 | 0.0b | 0.0 | 100.0 |
44 | 77.3a | 177.5 | 66.1a | 6.4 | 96.4 |
45 | 82.3a | 418.1 | 62.5a | 4.3 | 99.0 |
- 1 Each of 8 cats in the control group received no treatment. Each of 8 cats in the 19.5% w/v indoxacarb group were administered the topical spot-on according to label directions on Day 0.
- 2 Each cat was infested with 50 adult Ctenocephalides felis from the KS1 strain on days -2, 7, 14, 21, 28, 35 & 42.
- 3 Days post-treatment that eggs were collected.
- 4 % Adult emergence = (# of adults emerging/# of eggs collected) × 100.
- 5 Predicted emergence = (% emergence × geometric mean # eggs collected from Table 2).
- 6 % Efficacy = ((predicted adult emergence control-predicted adult emergence treatment)/geometric mean % adult emergence control) × 100.
- NE = no flea eggs collected.
- a,.b Values across rows with unlike superscripts are significantly different (P < 0.05).